Are the effects of a non-drug multimodal activation therapy of dementia sustainable? Follow-up study 10 months after completion of a randomised controlled trial

BMC Neurology (Impact Factor: 2.04). 12/2012; 12(1):151. DOI: 10.1186/1471-2377-12-151
Source: PubMed


Little is known about the long-term success of non-drug therapies for treating dementia, especially whether the effects are sustained after therapy ends. Here, we examined the effects of a one-year multimodal therapy 10 months after patients completed the therapy.
This randomised, controlled, single-blind, longitudinal trial involved 61 patients (catamnesis: n = 52) with primary degenerative dementia in five nursing homes in Bavaria, Germany. The highly standardised intervention, MAKS, consisted of motor stimulation, practice of activities of daily living (ADLs), and cognitive stimulation. Each group of 10 patients was treated for 2 h, 6 days a week for 12 months. Control patients received standard nursing home care. At baseline, at the end of therapy (month 12), and 10 months thereafter (month 22), cognitive functioning was assessed using the cognitive subscale of the Alzheimer’s Disease Assessment Scale, and the ability to perform ADLs was assessed using the Erlangen Test of Activities of Daily Living.
During the therapy phase, the MAKS patients maintained their cognitive function and ability to carry out ADLs. After the end of therapy, both the control and the MAKS groups deteriorated in both their cognitive function (control, p = 0.02; MAKS, p < 0.001) and their ability to carry out ADLs (control, p < 0.001; MAKS, p = 0.001). However, in a confound-adjusted multiple regression model, the ability of the MAKS group to perform ADLs remained significantly higher than that of the control group even 10 months after the end of therapy (H0: βMAKS + βMAKS month 22 = 0; χ2 = 3.8568, p = 0.0496). Cohen’s d for the difference between the two groups in ADLs and cognitive abilities 10 months after the end of therapy was 0.40 and 0.22, respectively.
A multimodal non-drug therapy of dementia resulted in stabilisation of the ability to perform ADLs, even beyond the end of therapy. To prevent functional decline for as long as possible, therapy should be performed continuously until the benefit for the patient ends. Follow-up studies on larger numbers of patients are needed to definitively confirm these results.
Trial registration Identifier: ISRCTN87391496

Download full-text


Available from: Katharina Luttenberger, Mar 04, 2015
  • Source
    • "These were observed in: a) a favorable effect of the intervention on basic ADL throughout the entire three year program, b) a favorable effect of the intervention on instrumental ADL only up to the second year, and c) a less clear effect in the cognitive domain, which appeared to improve marginally during the first year of intervention in comparison with the CG; however, the EG performed worse than the CG in terms of the cognitive assessment at the end of the study (Table 3, Figs. 2 and 3). Whereas the observed benefits in ADL are relevant and consistent with a previous study [12], the cognitive results should be cautiously interpreted, in part because of the attrition that was observed at the end of the study, particularly in the CG, which had double the mortality rate of the EG (Fig. 1 and Table 4). Differences in mortality between the two study groups may have produced a false impression of improvement in the CG, due to relatively high performance of the survivors. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Little is known about the long-term acceptance and effects of cognitive and motor stimulation interventions (CMSI) in Alzheimer's disease (AD). Objective: To evaluate a replicable CMSI program for mild cognitive impairment (MCI) and mild-to-moderate AD persons. Methods: Eighty-four non-institutionalized subjects with AD were randomized to receive either CMSI, administered by a single care provider, or standard support. Cognition, activities of daily living (ADL), mood, and study partner's subjective burden were assessed by blinded raters. Data on institutionalization, psychiatric medications, and demise were collected by the study physicians. Random effects model and survival analyses were conducted, after 2 and 3 years of study. Results: Three-year assessments could be performed by the physician in 85% and by the blinded rater in 66% of subjects. Significant benefits were observed in basic ADL at the 2- and 3-year assessments, whereas instrumental ADL showed benefits only up to the second year of intervention (p < 0.05). Conclusion: Long-term cognitive-motor stimulation is well accepted and produces functional benefits in subjects with AD, with no extra subjective burden in the partner.
    Journal of Alzheimer's disease: JAD 12/2014; 45(1). DOI:10.3233/JAD-142364 · 4.15 Impact Factor
  • Source
    • "Cognitive training is combined with other cognitive interventions. As cognitive deficits progress, additional interventions to CT are frequently introduced, with several studies finding improved cognitive function in MCI with CT and compensatory training in memory strategies [35] [50] [51], and slowed decline when CT is combined with CS in AD patients [33] [48] [56]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: There is much interest in early intervention for the prevention or postponement of dementia in Alzheimer's disease (AD). The results of drugs trials in this regard have thus far been disappointing, and non-pharmacological interventions are receiving increased attention. One such intervention is complex cognitive activity. Evidence from epidemiological studies suggests that participation in stimulating mental activities is associated with lowered dementia risk. The introduction of novel and complex cognitive interventions to healthy adults and those with cognitive impairment may represent an efficacious treatment option to improve cognition, lower dementia incidence, and slow rate of decline. This review examines the evidence for restorative cognitive training (CT) and addresses a number of clinically relevant issues regarding cognitive benefit and its transfer and persistence. Although the number of randomized controlled trials is limited, preliminary evidence suggests that CT may provide immediate and longer term cognitive benefits which generalize to non-trained domains and non-cognitive functions, with supervised small group multi-domain training providing greatest benefits. Possible neuroplastic mechanisms are discussed, and recommendations for further research and clinical implementation provided.
    Journal of Alzheimer's disease: JAD 08/2014; 42(Suppl 4):S551-S559. DOI:10.3233/JAD-141302 · 4.15 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Individual differences in theory of mind (ToM) are affected by a variety of factors. We investigated the relationship between empathy, sex and fluid intelligence (FI) as predictors of ToM in a random probabilistic sample of secondary students. First, we explored whether sex, as well as high, average or low levels of empathy and FI affect ToM performance. Furthermore, we assessed the contribution of empathy, sex and FI in predicting ToM by using a path analysis. This method allows testing of causal models of directed dependencies among a set of variables. The causal dependencies of empathy, sex and fluid intelligence were confirmed and identified. In addition, the model confirmed the direct effect of empathy, sex and fluid intelligence on ToM; and the indirect effect of sex mediated by empathy. Thus, individual differences in ToM levels are partially attributable to sex, empathy and fluid intelligence variability, raising important considerations for clinical research as well as ToM’s theoretical models of domain specificity.
    Personality and Individual Differences 04/2013; 54(5-5):616-621. DOI:10.1016/j.paid.2012.11.022 · 1.95 Impact Factor
Show more